O uso de medicamentos em puérpuras interfere nas recomendações quanto ao aleitamento materno?

Abstract

OBJECTIVE: To study the frequency of medication use in the immediate postpartum period and to evaluate possible effects on breastfeeding. METHODS: A cross-sectional study was carried out with 2,173 women that gave birth in four hospitals in Belo Horizonte, a city in the southeast of Brazil, between July 1998 and July 1999. The sample was calculated by means of the data obtained from the Citýs Health Department according to the number of labors made in these four hospitals in 1995, which amounts to approximately 5% of the total number that usually occurs within a year. Women were randomized according to the calendar of epidemiological weeks. The interviews consisted of a questionnaire through which information about breastfeeding and sociodemographic data were obtained. In addition, the data were collected from motherś and newbornś medical records. The drugs were classified according to their compatibility and incompatibility with breastfeeding, and were monitored as to the possible adverse effects on newborn infants. RESULTS: 2,090 (96.2%) of 2,173 women received drug therapy in the immediate postpartum period. Among the drugs used, 2,054 (98.3%) were not contraindicated for breastfeeding; 338 (16.2%) did not contain safe information, and 3 (0.14%) were contraindicated. CONCLUSIONS: Although drug therapy was widespread among the mothers followed up at these four hospitals, there seems to be no influence on breastfeeding. Fortunately, most prescribed drugs did not interfere with motherś and infantś health.

Consumo de medicamentos no período de internação para o parto

“…O uso de medicamentos no parto, do momento da internação até a alta, permanece pouco investigado embora represente um momento de alto risco de consumo. [5][6][7][8][9]11 Por ser limitado no tempo, em suas possibilidades terapêuticas e por sua forte importância sócio-cultural, representa um evento privilegiado na discussão sobre a racionalidade no consumo de medicamentos, com possibilidade de intervenção pouco discutida.…”

“…Em Belo Horizonte, cidade onde se realizou o presente estudo, uma investigação em cinco maternidades públicas no período 1998/1999 mostrou que 96,2% das parturientes usaram algum medicamento no pós-parto imediato, sendo que cerca de 16% pertenciam ao grupo dos produtos sem informações seguras sobre seus efeitos no recém-nascido. 6 Em estudo realizado por meio de levantamento de prontuários médicos, no início da década de 90, 14 observou-se que 79% das mulheres haviam tomado algum medicamento (entre um e 19), com média de 3,3 medicamentos por mulher. Esse estudo abrangeu o período de internação para o parto de 14.778 mulheres em 22 países.…”

“…6,12 Visando a contribuir para discussão do tema, o presente estudo analisa o perfil do consumo de medicamentos durante a permanência hospitalar para o parto em maternidade, estabelecendo assim base para comparações em diferentes locais.…”

Comparison of Cognitive-Executive Functions of the Frontal Lobe of the Brain and Lifestyle Self-Efficacy in Persons with Different Body Mass Indices

“…The overall prevalence of obesity in Iranian population is higher than the US, the UK, France, the Netherlands, and Italy (2). Several studies have noted that there is relationship between obesity in children and attention-deficit hyperactivity disorder (ADHD) (3,4). Some researchers believe that decreased level of cognitive functions is the result of obesity (5).…”

Passage des benzodiazépines dans le lait maternel : aspects cliniques et analytiques

“…La prescription est donc une analyse permanente du meilleur rapport bénéfice/risque. Cependant, la prescription d'un traitement médicamenteux à la mère allaitant est le plus souvent responsable d'un arrêt abusif de l'allaitement [11][12][13][14][15]. Afin d'estimer le degré d'exposition de l'enfant et l'éventuel impact du médicament sur celui-ci, il est nécessaire de connaître les mécanismes pharmacocinétiques du passage des médicaments dans le lait pour pouvoir choisir le traitement posant le moins de risque d'effets indésirables.…”